Viz.ai
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Viz.ai sits in the upper quartile of US sponsors by registered trial count (#2,085 of 15,742 sponsors by registered trial count).
Viz.ai: 6 sponsored US clinical trials, 2 recruiting.
Viz.ai sponsors 6 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 4 completed. The most-studied condition in this pipeline is Hypertrophic Cardiomyopathy, with 1 trials.
Upper-quartile sponsor footprint
Viz.ai sits in the upper quartile of the sponsor corpus (#2,085 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
6 total, page 1 of 1
COPD Exacerbation Follow Up
NCT07118306
VIZ ACCESS HCM - Multi-Site Registry
NCT07103057
Viz HCM (ECG Assist) Utilization Workflow Pilot
NCT06600256
SYNCHRONISE: LVO Triage Timing and Outcome Study
NCT04608617
ADVANCE- Automated Detection and Volumetric Assessment of ICH
NCT04733638
AI ENRICH - AI Detection of ICH
NCT03865979
Therapeutic Areas
What is open in the Viz.ai pipeline
2 recruiting of 6 indexed (33% open); 4 completed (67%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Hypertrophic Cardiomyopathy (1 trial), 0 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Viz.ai: open-pipeline peers nationwide
Peers matched on 6 registered trials and 33% open enrollment, not the therapeutic-area sidebar.
Viz.ai sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 6 trials (± recruiting share)
- 23andMe · 6 trials · 0% recruiting
- Aardvark Therapeutics · 6 trials · 0% recruiting
- Abbisko Therapeutics Co · 6 trials · 67% recruiting
- AbGenomics B.V Taiwan Branch · 6 trials · 0% recruiting
Sponsors near 33% open enrollment (± trial volume)
- Aadi Bioscience · 33% recruiting · 9 trials
- Aaron Cook · 33% recruiting · 3 trials
- Abivax S.A. · 33% recruiting · 6 trials
- Actuated Medical · 33% recruiting · 3 trials
Related
What to do with this Viz.ai page
6 registered trials is a research-attention snapshot, not an endorsement of Viz.ai or any single study.
- 2 of Viz.ai's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Hypertrophic Cardiomyopathy is the condition Viz.ai studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Hypertrophic Cardiomyopathy trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Viz.ai pipeline card: 6 registered trials from official public datasets.Report a data error.